Interest in these tumor associated macrophages as targets for cancer therapy has grown rapidly in recent years, especially in combination with conventional chemotherapy, radiotherapy, or immunotherapy. Monotherapies targeting TAMs, however, have shown limited evidence of anti-tumor activity. Read about a new study that, by elucidating the landscape of discreet macrophage niches, provides new insights for development of precision-targeted TAM-directed immunotherapies.